Day One Biopharmaceuticals Inc (DAWN)
13.27
-0.33
(-2.43%)
USD |
NASDAQ |
May 31, 16:00
13.27
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Price to Book Value: 3.907 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 3.907 |
| May 30, 2024 | 4.004 |
| May 29, 2024 | 4.051 |
| May 28, 2024 | 4.007 |
| May 24, 2024 | 4.054 |
| May 23, 2024 | 4.084 |
| May 22, 2024 | 4.305 |
| May 21, 2024 | 4.355 |
| May 20, 2024 | 4.702 |
| May 17, 2024 | 4.761 |
| May 16, 2024 | 4.720 |
| May 15, 2024 | 4.835 |
| May 14, 2024 | 4.894 |
| May 13, 2024 | 4.726 |
| May 10, 2024 | 4.711 |
| May 09, 2024 | 4.823 |
| May 08, 2024 | 4.832 |
| May 07, 2024 | 5.029 |
| May 06, 2024 | 4.888 |
| May 03, 2024 | 5.055 |
| May 02, 2024 | 5.173 |
| May 01, 2024 | 5.208 |
| April 30, 2024 | 5.034 |
| April 29, 2024 | 4.852 |
| April 26, 2024 | 4.392 |
| Date | Value |
|---|---|
| April 25, 2024 | 3.889 |
| April 24, 2024 | 4.472 |
| April 23, 2024 | 4.899 |
| April 22, 2024 | 4.528 |
| April 19, 2024 | 4.404 |
| April 18, 2024 | 4.637 |
| April 17, 2024 | 4.372 |
| April 16, 2024 | 4.301 |
| April 15, 2024 | 4.077 |
| April 12, 2024 | 4.054 |
| April 11, 2024 | 4.139 |
| April 10, 2024 | 4.242 |
| April 09, 2024 | 4.233 |
| April 08, 2024 | 4.110 |
| April 05, 2024 | 4.289 |
| April 04, 2024 | 4.180 |
| April 03, 2024 | 4.592 |
| April 02, 2024 | 4.663 |
| April 01, 2024 | 4.757 |
| March 28, 2024 | 4.165 |
| March 27, 2024 | 3.981 |
| March 26, 2024 | 3.913 |
| March 25, 2024 | 3.787 |
| March 22, 2024 | 3.921 |
| March 21, 2024 | 3.797 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.364
Minimum
May 27 2022
5.546
Maximum
Sep 01 2021
3.646
Average
3.699
Median
Mar 22 2023
Price to Book Value Benchmarks
| Revolution Medicines Inc | 3.665 |
| Iovance Biotherapeutics Inc | 3.654 |
| Beam Therapeutics Inc | 2.146 |
| Zentalis Pharmaceuticals Inc | 1.839 |
| Perspective Therapeutics Inc | 3.738 |
Price to Book Value Related Metrics
| PS Ratio | 0.587 |
| PEG Ratio | 0.0736 |
| Price | 13.27 |
| Earnings Yield | -18.91% |
| Market Cap | 1.160B |
| PEGY Ratio | 0.0736 |
| Operating PE Ratio | 4.318 |
| Normalized PE Ratio | 6.264 |